Clinical Trial Update: Ixazomib Citrate, Pomalidomide, Dexamethasone, Stem Cell Transplant in Treating Relapsed or Refractory Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ixazomib citrate, pomalidomide, dexamethasone with stem cell transplant in relapsed or refractory multiple myeloma has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Ixazomib citrate (Ixazomib)
• Pomalidomide (Pomalidomide)
• Stem cell transplant
• dexamethone (dexamethasone)

Snippet

Sponsor: Mayo Clinic | Conditions: Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2022-05-19